LYTIR

Company · ATTO

Attovia Therapeutics, Inc.

Nasdaq's symbol directory lists ATTO on Nasdaq as “Attovia Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 6 occasions ($42.1M); insiders sold on 1 occasion ($2.3M); 2 filings by holders of 5% or more.

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. GOLDMAN SACHS GROUP INC sold on 1 day bought on 2 days latest Aug 6, 2026 sold $2.3M · bought $10.3M
  2. Redmile Group, LLC bought on 1 day latest Aug 6, 2026 bought $10.2M
  3. Frazier Life Sciences XI, L.P. bought on 1 day latest Aug 6, 2026 bought $10.0M
  4. venBio Global Strategic Fund IV, L.P. bought on 1 day latest Aug 6, 2026 bought $6.5M
  5. Sanofi bought on 1 day latest Aug 6, 2026 bought $5.1M
Every trade (7)
  1. BUYRedmile Group, LLC bought Aug 6, 2026 600,000 shares 2 legs combined filing $10.2M
  2. BUYFrazier Life Sciences XI, L.P. bought Aug 6, 2026 588,235 shares filing $10.0M
  3. BUYGOLDMAN SACHS GROUP INC bought Aug 6, 2026 500,000 shares filing $8.5M
  4. BUYvenBio Global Strategic Fund IV, L.P. bought Aug 6, 2026 382,352 shares filing $6.5M
  5. BUYSanofi bought Aug 6, 2026 300,000 shares filing $5.1M
  6. SELLGOLDMAN SACHS GROUP INC sold Aug 5, 2026 105,807 shares 23 legs combined filing $2.3M
  7. BUYGOLDMAN SACHS GROUP INC bought Aug 5, 2026 85,000 shares filing $1.8M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Deep Track Capital, LP filed Aug 12, 2026 Schedule 13G passive 3,207,138 shares filing 7.45%
  2. Frazier Life Sciences Public Fund, L.P. filed Aug 11, 2026 Schedule 13D may seek influence 760,327 shares filing 1.7%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.